Menu Search Icon

Search

Department of Medicine Annual Report FY 2013

Publications

PUBLICATIONS: Endocrinology & Metabolism

Selected Publications 2012

  1. Abadir PM, Walston JD, Carey RM. Subcellular characteristics of functional intracellular renin-angiotensin systems. Peptides. 2012;38(2):437-45.
  2. Barrett EJ, Eringa EC. The vascular contribution to insulin resistance: promise, proof, and pitfalls. Diabetes. 2012;61(12):3063-5.
  3. Barrett EJ, Rattigan S. Muscle perfusion: its measurement and role in metabolic regulation. Diabetes. 2012;61(11):2661-8.
  4. Carey RM. Primary aldosteronism. J Surg Oncol. 2012;106(5):575-9.
  5. Carey RM, Schoeffel CD, Gildea JJ, Jones JE, McGrath HE, Gordon LN, Park MJ, Sobota RS, Underwood PC, Williams J, Sun B, Raby B, Lasky-Su J, Hopkins PN, Adler GK, Williams SM, Jose PA, Felder RA. Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension. 2012;60(5):1359-66.
  6. Eggleston E, Liu Z, Mirmira RG, Silva CM, Shu J, Santen RJ. Insights into mentorship for endocrinologists. J Clin Endocrinol Metab. 2012;97(11):3891-6.
  7. Gildea JJ, Wang X, Shah N, Tran H, Spinosa M, Van Sciver R, Sasaki M, Yatabe J, Carey RM, Jose PA, Felder RA. Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension. 2012;60(2):396-403.
  8. Gompel A, Santen RJ. Hormone therapy and breast cancer risk 10 years after the WHI. Climacteric. 2012;15(3):241-9.
  9. Harris TE, Thorner MO. Caloric restriction in mTORC1 control of intestinal homeostasis. Cell Metab. 2012;16(1):6-8.
  10. Kelly BN, Haverstick DM, Vance ML, Thorner MO, Bruns DE. Quantification of growth hormone mRNA in blood. Clin Chim Acta. 2012;414:206-10.
  11. Kemp BA, Bell JF, Rottkamp DM, Howell NL, Shao W, Navar LG, Padia SH, Carey RM. Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension. 2012;60(2):387-95.
  12. Lansey MN, Walker NN, Hargett SR, Stevens JR, Keller SR. Deletion of Rab GAP AS160 modifies glucose uptake and GLUT4 translocation in primary skeletal muscles and adipocytes and impairs glucose homeostasis. Am J Physiol Endocrinol Metab. 2012;303(10):E1273-86.
  13. Matavelli LC, Huang J, Siragy HM. In vivo regulation of renal expression of (pro)renin receptor by a low-sodium diet. Am J Physiol Renal Physiol. 2012;303(12):F1652-7.
  14. Meijer RI, De Boer MP, Groen MR, Eringa EC, Rattigan S, Barrett EJ, Smulders YM, Serne EH. Insulin-induced microvascular recruitment in skin and muscle are related and both are associated with whole-body glucose uptake. Microcirculation. 2012;19(6):494-500.
  15. Rosner MH, Dalkin AC. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Clin J Am Soc Nephrol. 2012;7(10):1722-9.
  16. Santen RJ, Yue W, Heitjan DF. Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy. Cancer Epidemiol Biomarkers Prev. 2012;21(7):1038-48.
  17. Sauder MA, Liu J, Jahn LA, Fowler DE, Chai W, Liu Z. Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans. J Clin Endocrinol Metab. 2012;97(7):E1208-12.
  18. Song Y, Santen RJ, Wang JP, Yue W. Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice. Endocrinology. 2012;153(12):5706-15.
  19. Wang H, Wang AX, Barrett EJ. Insulin-induced endothelial cell cortical actin filament remodeling: a requirement for trans-endothelial insulin transport. Mol Endocrinol. 2012;26(8):1327-38.

Selected Publications 2013

  1. Anderson A, Barrett EJ. Severe hypernatremia from a urea-induced diuresis due to body protein wasting in an insulin-resistant type 2 diabetic patient. J Clin Endocrinol Metab. 2013;98:1800-2.
  2. Barrett EJ, Liu Z. The endothelial cell: an “early responder” in the development of insulin resistance. Rev Endocr Metab Disord. 2013;14:21-7.
  3. Beller JP, McCartney CR. Cardiovascular risk and combined oral contraceptives: clinical decisions in settings of uncertainty. Am J Obstet Gynecol. 2013;208:39-41.
  4. Carey RM. The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure. Hypertension. 2013;61:673-80.
  5. Carey RM. Resistant hypertension. Hypertension. 2013;61:746-50.
  6. Carey RM, Padia SH. Role of angiotensin AT2 receptors in natriuresis: Intrarenal mechanisms and therapeutic potential. Clin Exp Pharmacol Physiol. 2013 Aug;40:527-34.
  7. Dong Z, Chai W, Wang W, Zhao L, Fu Z, Cao W, Liu Z. Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment. Am J Physiol Endocrinol Metab. 2013;304(2):E222-8.
  8. Eggleston EM, Jahn LA, Barrett EJ. Early microvascular recruitment modulates subsequent insulin-mediated skeletal muscle glucose metabolism during lipid infusion. Diabetes Care. 2013;36:104-10.
  9. Genders AJ, Frison V, Abramson SR, Barrett EJ. Endothelial cells actively concentrate insulin during its transendothelial transport. Microcirculation. 2013;20:434-9.
  10. Gildea JJ, Carlson JM, Schoeffel CD, Carey RM, Felder RA. Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure. Clin Biochem. 2013;46:1131-4.
  11. Gildea JJ, Lahiff DT, Van Sciver RE, Weiss RS, Shah N, McGrath HE, Schoeffel CD, Jose PA, Carey RM, Felder RA. A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy. Clin Chim Acta. 2013;421:236-42.
  12. Gupta RK, Kuppusamy T, Patrie JT, Gaylinn B, Liu J, Thorner MO, Bolton WK. Association of Plasma Des-acyl Ghrelin Levels with CKD. Clin J Am Soc Nephrol. 2013;8:1098-105.
  13. Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB Jr, Chipman JJ, Melmed S; International HypoCCS Advisory Board. Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients. J Clin Endocrinol Metab. 2013;98:980-8.
  14. Huang J, Ledford KJ, Pitkin WB, Russo L, Najjar SM, Siragy HM. Targeted Deletion of Murine CEACAM 1 Activates PI3K-Akt Signaling and Contributes to the Expression of (Pro)Renin Receptor via CREB Family and NF-κB Transcription Factors. Hypertension. 2013 Aug;62(2):317-23.
  15. Kemp BA, Howell NL, Gildea JJ, Keller SR, Padia SH. Intrarenal ghrelin receptors regulate ENaC-dependent sodium reabsorption by a cAMP-dependent pathway. Kidney Int. 2013 May 22. doi: 10.1038/ki.2013.187. [Epub ahead of print]
  16. Liu Z. The vascular endothelium in diabetes and its potential as a therapeutic target. Rev Endocr Metab Disord. 2013;14:1-3.
  17. Matavelli LC, Siragy HM. Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats. J Cardiovasc Pharmacol. 2013;61:17-22.
  18. McCall AL, Farhy LS. Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control. Minerva Endocrinol. 2013;38:145-63.
  19. Padia SH, Carey RM.AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflugers Arch. 2013;465:99-110.
  20. Nass R. Growth hormone axis and aging. Endocrinol Metab Clin North Am. 2013;42:187-99.
  21. Santen RJ, Song Y, Yue W, Wang JP, Heitjan DF. Effects of menopausal hormonal therapy on occult breast tumors. J Steroid Biochem Mol Biol. 2013 Jun 7. doi:pii: S0960-0760(13)00079-4.
  22. Santen RJ, Yue W, Heitjan DF. Occult breast tumor reservoir: biological properties and clinical significance. Horm Cancer. 2013;4:195-207.
  23. Selkow NM, Herman DC, Liu Z, Hertel J, Hart JM, Saliba SA. Microvascular perfusion increases after eccentric exercise of the gastrocnemius. J Ultrasound Med. 2013;32:653-8.
  24. Song Y, Santen RJ, Wang JP, Yue W. Inhibitory effects of a bazedoxifene/conjugated equine estrogen combination on human breast cancer cells in vitro. Endocrinology. 2013;154:656-65.
  25. Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab. 2013;98:3190-8.
  26. Swift DL, Weltman JY, Patrie JT, Barrett EJ, Gaesser GA, Weltman A. Evaluation of racial differences in resting and postprandial endothelial function in postmenopausal women matched for age, fitness and body composition. Ethn Dis. 2013;23:43-8.
  27. Vance ML. Medical management of Cushing’s Syndrome. Endocr Pract. 2013; 21:1-4.
  28. Waeber B, Siragy HM. Mild hypertension: to treat or not to treat? Curr Hypertens Rep. 2013;15:1-2.
  29. Wang N, Chai W, Zhao L, Tao L, Cao W, Liu Z. Losartan increases muscle insulin delivery and rescues insulin’s metabolic action during lipid infusion via microvascular recruitment. Am J Physiol Endocrinol Metab. 2013;304:E538-45.
  30. Yue W, Yager JD, Wang JP, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids. 2013;78:161-70.
  31. Zhao L, Chai W, Fu Z, Dong Z, Aylor KW, Barrett EJ, Cao W, Liu Z. Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery. Circ Res. 2013;112:1263-71.
In This Section down-arrow
Menu